Fortrea Holdings (FTRE) Operating Expenses (2022 - 2026)

Fortrea Holdings (FTRE) posted Operating Expenses of $639.9 million for Q1 2026, down 5.07% on a QoQ basis from $674.1 million in Q4 2025, and down 45.37% year-over-year from $1.2 billion in Q1 2025.

Fortrea Holdings (FTRE) Operating Expenses (2022 - 2026) Analysis & Trends

Fortrea Holdings' Operating Expenses history runs 5 years deep, the most recent figure standing at $639.9 million for Q1 2026.

  • Quarterly Operating Expenses fell 45.37% year-over-year to $639.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.1 billion (down 7.98% YoY) and the FY2025 annual result came in at $3.6 billion, up 25.81% from the prior year.
  • Operating Expenses was $639.9 million for Q1 2026 at Fortrea Holdings, down from $674.1 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $1.2 billion in Q1 2025 and bottomed at $488.3 million in Q4 2022.
  • A 5-year average of $738.0 million and a median of $701.5 million in 2023 frame the typical range for Operating Expenses.
  • Annual changes were most pronounced in 2025 — Operating Expenses jumped 67.46% — and 2026, when it sank 45.37%.
  • Fortrea Holdings' Operating Expenses stood at $488.3 million in 2022, then soared by 50.26% to $733.7 million in 2023, then rose by 2.58% to $752.6 million in 2024, then dropped by 10.43% to $674.1 million in 2025, then fell by 5.07% to $639.9 million in 2026.
  • Business Quant data shows FTRE's Operating Expenses at $639.9 million in Q1 2026, $674.1 million in Q4 2025, and $709.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -28.01 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.10 Bn
4 NuCana 279.75 Bn 279.75 Bn - -3.78 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.85 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 2.96 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 32.68 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 2.89 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 445.22 Mn
10 Fortrea Holdings 1.83 Bn 1.68 Bn 123.60 Mn 639.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 639.90 Mn
Dec 31, 2025 674.10 Mn
Sep 30, 2025 709.90 Mn
Jun 30, 2025 1.04 Bn
Mar 31, 2025 1.17 Bn
Dec 31, 2024 752.60 Mn
Sep 30, 2024 692.90 Mn
Jun 30, 2024 713.30 Mn
Mar 31, 2024 699.50 Mn
Dec 31, 2023 733.70 Mn
Sep 30, 2023 703.50 Mn
Jun 30, 2023 693.50 Mn
Mar 31, 2023 679.80 Mn
Dec 31, 2022 488.30 Mn
Sep 30, 2022 693.40 Mn
Jun 30, 2022 721.90 Mn